°®ÍþÄÌapp

Close

Publications

Luangasanatip, N; FLASCHE, S; DANCE, DA B; Limmathurotsakul, D; Currie, BJ; Mukhopadhyay, C; Atkins, T; Titball, R; JIT, M;
2019
BMC Medicine, (2019).17 1
FLASCHE, S; WILDER-SMITH, A; Hombach, J; SMITH, PG;
2019
Wellcome open research, (2019).4,
Mosser, JF; Gagne-Maynard, W; Rao, PC; Osgood-Zimmerman, A; Fullman, N; Graetz, N; Burstein, R; Updike, RL; Liu, PY; Ray, SE; Earl, L; Deshpande, A; Casey, DC; Dwyer-Lindgren, L; Cromwell, EA; Pigott, DM; Shearer, FM; LARSON, HJ; Weiss, DJ; Bhatt, S; Gething, PW; Murray, CJ L; Lim, SS; Reiner, RC; Hay, SI;
2019
Lancet, (2019).393 10183
CLARK, A; VAN ZANDVOORT, K; FLASCHE, S; SANDERSON, C; Bines, J; Tate, J; Parashar, U; JIT, M;
2019
LANCET INFECTIOUS DISEASES, (2019).19 7
Liu, D; Leung, K; JIT, M; Yu, H; Yang, J; Liao, Q; Liu, F; Zheng, Y; Wu, JT;
2019
Clinical microbiology and infection, (2019).26 3
Mathematical modelling of the epidemiological impact, budget impact and cost-effectiveness of novel tuberculosis vaccines on multidrug-resistant tuberculosis [Oral Presentation].
WEERASURIYA, C; Harris, R; BOZZANI, F; Gomez, GB; WHITE, R;
2019
International Journal of Tuberculosis and Lung Disease, (2019).23 10
Simas, C; Munoz, N; Arregoces, L; LARSON, HJ;
2019
HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2019).15 5
FRANCIS, MR; Nuorti, JP; Kompithra, RZ; LARSON, H; Balraj, V; Kang, G; Mohan, VR;
2019
Vaccine, (2019).37 23
Esposito, S; Stefanelli, P; Fry, NK; Fedele, G; He, Q; PATERSON, P; Tan, T; Knuf, M; Rodrigo, C; Weil Olivier, C; Flanagan, KL; Hung, I; Lutsar, I; Edwards, K; O'Ryan, M; Principi, N; World Association of Infectious Diseases and Immun,;
2019
FRONTIERS IN IMMUNOLOGY, (2019).10 JUL
PEARSON, CA B; ABBAS, KM; CLIFFORD, S; FLASCHE, S; Hladish, TJ;
2019
Journal of The Royal Society Interface, (2019).16 157